New pain block combo could ease knee replacement recovery for seniors
NCT ID NCT07418307
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two ways to numb the knee after total knee replacement in 50 elderly patients. One method combines two nerve blocks, the other uses a single block. Researchers will measure how long pain relief lasts and how much extra pain medicine is needed. The goal is to find a safer, more effective option for older adults.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bupivacaine and dexamethasone
- What this could lead to
- If successful, this could point toward a better way to manage pain after knee replacement, reducing the need for strong painkillers.
- What could go wrong
- This is a small, early-stage study with only 50 participants, so results may not apply to everyone. The nerve blocks carry risks like infection or nerve damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patient acceptance * Physical status: ASA I, II and Ⅲ. * Body mass index (BMI): 18.5 - 35 kg/m2. * Type of operations: total knee arthroplasty. Exclusion Criteria: * Known hypersensitivity to dexamethasone or bupivacaine. * Coagulation disorders or taking drugs affect surgical hemostasis. * Patients with pre-existing neurological deficits. * Uncooperative patient or with altered mental status. * Patient with advanced cardiovascular or respiratory diseases or uncontrolled diabetes
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Knee arthroplasty, total are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Faculty of Medicine,Zagazig University
Zagazig, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a robot make a new knee feel like your own?
- A Non-Opioid painkiller may cut opioid use after knee surgery
- Knee replacement patients may skip hospital visits with remote monitoring
- Knee replacement patients may get faster recovery with continuous nerve block
- New CT scan could spot loose knee implants sooner
- Why do some patients still hurt after joint replacement?